News
Hims agreed to buy private European telehealth firm Zava, which operates in the U.K., Germany, France, and Ireland.
After experiencing high growth in the U.S. telehealth scene, Hims is taking its personalized obesity treatments ...
HIMS showcases outstanding financial strength. With just $63 million in debt against a market value of $13 billion, the ...
Investors are buying Hims & Hers Health ( HIMS 10.09%) stock hand over fist after the mail-order drugs company reported an earnings miss but a sales beat last night. But they're selling off shares of ...
US telehealth group explores selling ‘compounded medications’ in new markets after buying London-based rival Zava ...
The direct-to-consumer telehealth company said the workforce reduction is unrelated to its weight-loss drug sector.
Hims & Hers is evolving beyond its original focus, aggressively expanding into peptides and GLP-1. Read why I reiterate my ...
Just 14 stocks with market caps above $1 billion have doubled so far this year. They probably aren't the winners you would ...
Hims & Hers teams up with Novo Nordisk to bundle Wegovy into a $599/month telehealth care plan. Investors see Amazon-like potential as Hims scales affordable healthcare through platform-based ...
Hims & Hers Health continues to fire on all cylinders as a business. Click here to read why HIMS stock is a Buy.
Telehealth platform Hims & Hers will cut 68 employees, or about 4% of its workforce, as it adjusts to a U.S. ban on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback